These results not only demonstrate the significant involvement of MCP-1 in EM development but also highlight the complex interplay between the endocrine and immune systems, showing the crucial role of oestrogen in amplifying the chemokine-induced recruitment of immune mediators to the sites of endometriotic lesions. The gene discussed is CCL2; the disease is erythema multiforme.